http://www.has-sante.fr/portail/jcms/c_1671509/fr/optison http://www.has-sante.fr/portail/jcms/c_1671508/fr/optison-16102013-avis-ct12724 2013 France French evaluation of the transparency committee perflutren contrast media FS 069 perfluoropropane-filled albumin microsphere solution echocardiography cardiovascular diseases perflutren, human albumin microspheres fluorocarbons albumins
--- https://www.ema.europa.eu/medicines/human/EPAR/Luminity 2012 United Kingdom French English syndication feed coronary disease fluorocarbons phospholipids fluorocarbons contrast media drug evaluation microspheres echocardiography injections, intravenous infusions, intravenous fluorocarbons contrast media adult pregnancy breast feeding fluorocarbons contrast media drug evaluation, preclinical fluorocarbons contrast media drug storage drug compounding drug approval perflutren perflutren, phospholipid microspheres fluorocarbons package leaflet drug evaluation summary of product characteristics
--- https://www.ema.europa.eu/medicines/human/EPAR/Optison 2011 United Kingdom French English syndication feed fluorocarbons contrast media cardiovascular diseases echocardiography fluorocarbons contrast media drug labeling drug approval drug evaluation injections, intravenous heart ventricles pregnancy breast feeding drug compounding perflutren perflutren perflutren, human albumin microspheres fluorocarbons package leaflet drug evaluation summary of product characteristics
--- https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/14501a-fra.php 2008 Canada French English perflutren contrast media drug monitoring continuity of patient care injections fluorocarbons lung diseases cardiovascular diseases fluorocarbons pharmacovigilance note